share_log

UBS Adjusts Price Target on Quest Diagnostics to $166 From $165, Maintains Neutral Rating

UBS Adjusts Price Target on Quest Diagnostics to $166 From $165, Maintains Neutral Rating

瑞银将奎斯特诊疗的目标股价调整至166美元,维持中立评级
MT Newswires ·  10/23 08:34  · 评级/大行评级

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发